Emgold Extends Warrants and Retains Investor Relations Firm
VANCOUVER, BC / ACCESSWIRE / February 22, 2021 / Emgold Mining Corporation (TSXV:EMR)(OTC PINK:EGMCF)(FRA:EMLM) (“Emgold”…
VANCOUVER, BC / ACCESSWIRE / February 22, 2021 / Emgold Mining Corporation (TSXV:EMR)(OTC PINK:EGMCF)(FRA:EMLM) (“Emgold”…
In an effort to effectively target people with various forms of drug addiction, some of…
CALGARY, AB / ACCESSWIRE / February 22, 2021 / Ivrnet Inc. (TSXV:IVI) (“Ivrnet” or the…
Recording a complete and accurate record of network activity lets analysts quickly troubleshoot security threats…
PRESS RELEASE NEW INDEPENDENT PUBLICATION IN THE PEER-REVIEWED SCIENTIFIC REVIEW CELLS…
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN…
PRESS RELEASE Emergex Strengthens Senior Management Team Appointments of Mr Robin Cohen as Business Development…
Bagsværd, Denmark, 23 February 2021 – The Annual General Meeting of Novo Nordisk A/S will…
Online event will examine present and future of California’s growing cannabis market and the role…
LOS ANGELES, Feb. 22, 2021 (GLOBE NEWSWIRE) — Enochian BioSciences, a company focused on gene-modified…
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL),…
GAITHERSBURG, Md., Feb. 22, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…
SAN DIEGO, Feb. 22, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR…
Insights from Pr. Sven Francque and Dr. Kris V. Kowdley on PBC, a chronic, cholestatic,…
AUSTIN, Texas, Feb. 22, 2021 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical…
PORTLAND, Maine , Feb. 22, 2021 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”),…
– Positive interim data through cohort five for the ReSPECT™ Phase 1 clinical trial in…
CARLSBAD, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading…